T
Telcon RF Pharmaceutical Inc
KOSDAQ:200230
Telcon RF Pharmaceutical Inc
KOSDAQ:200230
Price:
772
KRW
2.25%
Market Closed
Market Cap:
₩52.9B
Balance Sheet
Balance Sheet Decomposition
Telcon RF Pharmaceutical Inc
Telcon RF Pharmaceutical Inc
Balance Sheet Decomposition is not available for
Telcon RF Pharmaceutical Inc
Telcon RF Pharmaceutical Inc
Balance Sheet
Telcon RF Pharmaceutical Inc
Telcon RF Pharmaceutical Inc
Currency: KRW
| Dec-2011 | Dec-2012 | Dec-2013 | Dec-2014 | Dec-2015 | Dec-2016 | Dec-2017 | Dec-2018 | Dec-2019 | Dec-2020 | Dec-2021 | Dec-2022 | Dec-2023 | Dec-2024 | ||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Assets | |||||||||||||||
| Cash & Cash Equivalents |
792
|
2 454
|
12 415
|
21 078
|
18 050
|
8 863
|
16 446
|
7 239
|
15 728
|
24 542
|
23 195
|
9 734
|
8 519
|
3 306
|
|
| Cash |
1
|
2
|
8
|
5
|
0
|
4
|
2
|
2
|
4
|
4
|
2
|
4
|
8
|
0
|
|
| Cash Equivalents |
791
|
2 452
|
12 407
|
21 073
|
18 050
|
8 859
|
16 444
|
7 237
|
15 724
|
24 538
|
23 193
|
9 730
|
8 511
|
3 306
|
|
| Short-Term Investments |
140
|
140
|
2 160
|
6 000
|
6 993
|
2 000
|
13 535
|
128
|
160
|
189
|
0
|
2 230
|
2 000
|
6 731
|
|
| Total Receivables |
13 226
|
13 514
|
10 509
|
11 764
|
13 456
|
15 743
|
12 100
|
13 306
|
12 381
|
10 768
|
9 747
|
6 455
|
16 284
|
9 321
|
|
| Accounts Receivables |
10 211
|
13 263
|
10 300
|
10 970
|
13 420
|
11 521
|
9 848
|
12 368
|
11 931
|
8 550
|
9 479
|
6 139
|
9 046
|
8 790
|
|
| Other Receivables |
3 015
|
251
|
209
|
794
|
36
|
4 222
|
2 252
|
938
|
450
|
2 218
|
268
|
316
|
7 238
|
531
|
|
| Inventory |
3 081
|
3 278
|
3 089
|
4 150
|
1 868
|
3 936
|
3 450
|
4 492
|
4 189
|
4 276
|
4 303
|
4 622
|
5 003
|
4 956
|
|
| Other Current Assets |
220
|
73
|
195
|
553
|
945
|
7 626
|
6 149
|
459
|
135
|
482
|
111
|
86
|
1 183
|
1 697
|
|
| Total Current Assets |
17 459
|
19 459
|
28 367
|
43 546
|
41 313
|
38 169
|
51 680
|
25 624
|
32 593
|
40 257
|
37 357
|
23 127
|
32 989
|
26 011
|
|
| PP&E Net |
416
|
530
|
1 182
|
1 689
|
1 501
|
7 157
|
16 117
|
6 641
|
7 107
|
8 417
|
9 320
|
8 038
|
8 468
|
11 180
|
|
| PP&E Gross |
416
|
530
|
1 182
|
1 689
|
0
|
7 157
|
16 117
|
6 641
|
7 107
|
8 417
|
9 320
|
8 038
|
8 468
|
11 180
|
|
| Accumulated Depreciation |
1 136
|
1 320
|
1 485
|
1 799
|
0
|
6 245
|
7 661
|
10 001
|
11 428
|
11 620
|
12 292
|
14 237
|
15 541
|
16 979
|
|
| Intangible Assets |
20
|
23
|
193
|
332
|
260
|
11 830
|
41 376
|
44 806
|
31 285
|
32 153
|
30 201
|
23 881
|
21 338
|
18 738
|
|
| Goodwill |
0
|
0
|
0
|
0
|
0
|
24 586
|
25 903
|
4 179
|
4 179
|
0
|
0
|
0
|
0
|
0
|
|
| Note Receivable |
300
|
0
|
0
|
0
|
3 400
|
0
|
0
|
0
|
24
|
0
|
0
|
34
|
46
|
70
|
|
| Long-Term Investments |
45
|
300
|
300
|
0
|
1 680
|
39 638
|
73 594
|
99 486
|
55 406
|
103 415
|
90 287
|
63 375
|
76 722
|
96 767
|
|
| Other Long-Term Assets |
2 012
|
1 992
|
2 154
|
2 191
|
0
|
3 132
|
973
|
1 059
|
1 053
|
810
|
865
|
800
|
851
|
822
|
|
| Other Assets |
0
|
0
|
0
|
0
|
0
|
24 586
|
25 903
|
4 179
|
4 179
|
0
|
0
|
0
|
0
|
0
|
|
| Total Assets |
20 252
N/A
|
22 304
+10%
|
32 196
+44%
|
47 759
+48%
|
48 155
+1%
|
124 512
+159%
|
209 642
+68%
|
181 795
-13%
|
131 648
-28%
|
185 053
+41%
|
168 030
-9%
|
119 255
-29%
|
140 415
+18%
|
153 588
+9%
|
|
| Liabilities | |||||||||||||||
| Accounts Payable |
3 101
|
3 153
|
3 535
|
1 387
|
3 774
|
7 346
|
4 139
|
4 809
|
2 352
|
2 639
|
2 630
|
2 668
|
2 581
|
2 818
|
|
| Accrued Liabilities |
378
|
356
|
461
|
116
|
0
|
584
|
924
|
832
|
636
|
1 108
|
902
|
720
|
698
|
900
|
|
| Short-Term Debt |
0
|
0
|
0
|
0
|
0
|
2 380
|
12 952
|
7 467
|
25
|
25
|
0
|
200
|
0
|
18 600
|
|
| Current Portion of Long-Term Debt |
5 812
|
2 522
|
3 226
|
1 122
|
0
|
9 339
|
49 040
|
11 693
|
10 390
|
85 717
|
54 635
|
29 347
|
27 020
|
36 501
|
|
| Other Current Liabilities |
256
|
1 273
|
2 064
|
1 546
|
26
|
4 103
|
3 199
|
1 535
|
1 201
|
1 433
|
1 946
|
1 394
|
4 625
|
10 901
|
|
| Total Current Liabilities |
9 547
|
7 304
|
9 286
|
4 171
|
3 799
|
23 751
|
70 254
|
26 336
|
14 603
|
90 921
|
60 113
|
34 329
|
34 924
|
69 720
|
|
| Long-Term Debt |
0
|
0
|
0
|
0
|
0
|
9 242
|
4 168
|
0
|
1 758
|
2 574
|
1 301
|
728
|
403
|
590
|
|
| Deferred Income Tax |
0
|
0
|
304
|
281
|
353
|
1 823
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Minority Interest |
0
|
0
|
0
|
0
|
0
|
22 488
|
26 811
|
1 422
|
1 270
|
136
|
28
|
12
|
485
|
305
|
|
| Other Liabilities |
283
|
53
|
99
|
97
|
10
|
1 249
|
724
|
7
|
1
|
81
|
8
|
63
|
143
|
143
|
|
| Total Liabilities |
9 830
N/A
|
7 358
-25%
|
9 689
+32%
|
4 550
-53%
|
4 162
-9%
|
58 553
+1 307%
|
101 957
+74%
|
27 765
-73%
|
17 632
-36%
|
93 714
+431%
|
61 450
-34%
|
35 132
-43%
|
35 956
+2%
|
70 759
+97%
|
|
| Equity | |||||||||||||||
| Common Stock |
1 250
|
1 250
|
2 000
|
2 511
|
2 511
|
5 810
|
7 271
|
8 233
|
8 528
|
8 751
|
9 991
|
10 860
|
11 599
|
12 025
|
|
| Retained Earnings |
9 173
|
13 697
|
20 577
|
27 323
|
27 681
|
24 243
|
7 002
|
7 509
|
60 158
|
103 212
|
126 310
|
168 048
|
154 142
|
180 462
|
|
| Additional Paid In Capital |
0
|
0
|
0
|
13 318
|
13 318
|
32 668
|
94 010
|
150 888
|
164 327
|
180 991
|
216 003
|
238 108
|
243 907
|
245 985
|
|
| Unrealized Security Profit/Loss |
0
|
0
|
0
|
0
|
0
|
3 085
|
806
|
665
|
428
|
4 252
|
5 923
|
3 021
|
2 929
|
5 152
|
|
| Other Equity |
0
|
0
|
70
|
57
|
482
|
153
|
208
|
1 754
|
891
|
557
|
973
|
182
|
165
|
129
|
|
| Total Equity |
10 423
N/A
|
14 947
+43%
|
22 507
+51%
|
43 209
+92%
|
43 992
+2%
|
65 959
+50%
|
107 685
+63%
|
154 030
+43%
|
114 016
-26%
|
91 339
-20%
|
106 580
+17%
|
84 123
-21%
|
104 459
+24%
|
82 830
-21%
|
|
| Total Liabilities & Equity |
20 252
N/A
|
22 304
+10%
|
32 196
+44%
|
47 759
+48%
|
48 155
+1%
|
124 512
+159%
|
209 642
+68%
|
181 795
-13%
|
131 648
-28%
|
185 053
+41%
|
168 030
-9%
|
119 255
-29%
|
140 415
+18%
|
153 588
+9%
|
|
| Shares Outstanding | |||||||||||||||
| Common Shares Outstanding |
9
|
9
|
15
|
19
|
19
|
22
|
27
|
31
|
32
|
32
|
37
|
40
|
43
|
45
|
|
Switch to:
Switch to:
See Also
Discover More
